Hyderabad, India, March 22, 2017 -- The report “Epigenetics Market: By Products (Kits, Reagents, Enzymes, Others), By Application (Diagnostics, Drugs, Others), By End Users (Research Institutes, Diagnostic Centers, Others) - Forecast (2017-2022)”, published by IndustryARC, estimates that with an increasing interest in explaining the cause and effect relationship between human health and external factors, the market’s scope will show a steady upslope in North America and APAC.
Browse numerous Market Tables and Figures spread through 89 Pages and an in-depth TOC on “Epigenetics Market 2017 – 2022”
http://industryarc.com/Report/10610/epigenetics-market.html
Scope & Regional Forecast of the Epigenetics Market:
During the last decade, the healthcare segment has achieved incredible feats and the Human Genome Project has been an important achievement for mankind. It provided the researchers access to a new paradigm in the field of genetics. Epigenetics is one such concept which has gained immense traction in the last decade. Epigenetics is the chemical code which is present on top of the DNA sequence which has the ability to alter the human behavior. There are different types of epigenomes such as methyl, acetyl and phosphate groups. Epigenetics is making enormous efforts in explaining the cause and effect relationship between human health and external factors such as diet, sleeping habits and even stress.
Request Sample PDF Brochure @ http://industryarc.com/pdfdownload.php?id=10610
The market is largely dominated by North America which accounts for major share of the global market which is followed by emerging markets of APAC. Countries such as India, Mexico, Brazil, are have experienced immense growth over the past few years. These countries are expected to offer high potential due to the growing economy.
This report gives detailed information about the product value chain right from the beginning which includes raw materials till end-use. The market is analyzed based on the key attributes such as the power in the hands of producers and consumers, analysis on the degree of competition, and threats from substitutes and new entrants. The study includes the demand of this particular market on a global and regional scale for a six year period of 2016-2021, both in terms of volume and revenue.
Inquiry before buying report @ http://industryarc.com/inquiry-before-buying.php?id=10610
Prominent Segmentations Involved in the Epigenetics Market:
- The Products: Kits (Bisulfite Conversion Kit, Chromatin Immunoprecipitation Seq (ChIP) Kit, Histone Purification Kit, RNA sequencing Kit and Others).
- Reagents: Antibodies, Histones, Proteins and Others.
- Enzymes: DNA (DNA Polymerases).
- Instruments: (Next-generation Sequencers, Mass Spectrometers, PCRs and Others).
- Application: Diagnostics (Cancer Therapy), Drugs, Developmental Biology and Others.
- End Users: Research Institutes, Diagnostic Centers and Others.
- Geographic Regions: North America, Europe, APAC and ROW.
Some of the sample companies profiled in the Epigenetics Market report are as follows:
- Pfizer Inc.
- Progen Pharmaceuticals Ltd.
- Promega Corporation
- Proteros biostructures GmbH
- QIAGEN
- RaNA Therapeutics Inc.
- Reliv International
- Roche Sequencing
- Rodin Therapeutics
- Sigma-Aldrich Co. LLC
- Structural Genomics Consortium
- Takeda Pharmaceutical Co. Ltd
- Tensha Therapeutics Inc.
- The Epigenetics Company
- The Rockefeller University
Why buy this report?
- Get a detailed picture of the Epigenetics Market.
- Pinpoint growth sectors and identify factors driving change.
- Understand the competitive environment, the market’s major players and leading brands.
- A five-year forecast method is used in order to assess how the market is predicted to develop.
Purchase Epigenetics Market Report @ http://industryarc.com/purchasereport.php?id=10610
Browse Related Reports:
Genome Editing/Genome Engineering Market: By Technology (CRISPR, TALEN, ZFN), Applications (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology & Pharmaceutical Companies, CROs - Global Forecast to 2017 - 2025
http://industryarc.com/Report/16719/genome-editinggenome-engineering-market.html
Genotyping Market: By Technology (Polymerase Chain Reaction, Sequencing, Microarray, Electrophoresis, MALDI_TOF), Application (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology) & by Products - Global Forecast to 2017 - 2025
http://industryarc.com/Report/16753/genotyping-market.html
About IndustryARC:
IndustryARC is a research and consulting firm that publishes more than 500 Reports Annually in various industries, such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences & Healthcare.
IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights on the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business.
We look forward to support the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today.
Media Contact
Mr. Sanjay Matthews
Business Development Manager
Email: [email protected]
Contact Sales: 1-614-588-8538 (Ext-101)
Connect with us on LinkedIn - https://www.linkedin.com/company/industryarc
Know more about IndustryARC Events: http://industryarc.com/events.php


Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



